article thumbnail

Tome Biosciences debuts with $213M and a new way to edit the genome

Bio Pharma Dive

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genomics 328
article thumbnail

Tome acquires startup Replace, gaining new genome editing tools

Bio Pharma Dive

The deal is the second startup sale engineered by University of California, Berkeley scientist Shakked Halperin, and gives Tome a way to insert or delete small DNA sequences into the genome.

Genomics 169
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Al Sandrock, former top Biogen scientist, to join drug discovery startup's board

Bio Pharma Dive

Sandrock's appointment to Verge Genomics' board of directors follows about a week after the executive took up a similar post with Voyager Therapeutics.

Scientist 246
article thumbnail

Scientists develop largest ever biological AI model that ‘thinks in nucleotides’

Pharmaceutical Technology

A team of scientists has developed a new AI-based foundation model that can give insights into disease-causing mutations and genome design.

Scientist 147
article thumbnail

Scientists sequence Beethoven's genome for clues into his painful past

NPR Health - Shots

Scientists have sequenced the genome of Ludwig van Beethoven from two-century-old locks of hair, and found clues about the ailments that plagued him in life. Image credit: Henry Guttmann Collection/Getty Images)

Genomics 102
article thumbnail

Scientists expand entomological research using genome editing

Scienmag

Genome sequencing, where scientists use laboratory methods to determine a specific organism’s genetic makeup, is becoming a common practice in insect research.

article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

Genome 129